Combination therapy of an afucosylated CD20 antibody with fludarabine and/or mitoxantrone

Details for Australian Patent Application No. 2010281867 (hide)

Owner Roche Glycart AG

Inventors Dreyling, Martin; Heinrich, Daniel Alexander; Herting, Frank; Klein, Christian

Agent Griffith Hack

Pub. Number AU-A-2010281867

PCT Pub. Number WO2011/018225

Priority 09010488.6 14.08.09 EP; 10162391.6 10.05.10 EP

Filing date 12 August 2010

Wipo publication date 17 February 2011

International Classifications

C07K 16/28 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies

A61K 31/137 (2006.01) - Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine

A61K 31/70 (2006.01) - Carbohydrates

A61K 39/395 (2006.01) Medicinal preparations containing antigens or antibodies - Antibodies

A61P 35/00 (2006.01) Antineoplastic agents

Event Publications

2 February 2012 PCT application entered the National Phase

  PCT publication WO2011/018225 Priority application(s): WO2011/018225

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2010281869-Peptide libraries

2010281866-Combination therapy of an afucosylated CD20 antibody with bendamustine